½ÃÀ庸°í¼­
»óǰÄÚµå
1296745

Äݶó°Õ ÆéŸÀÌµå ½ÃÀå ¿¹Ãø(-2030³â) - °ø±Þ¿ø, ÇüÅ ¹× ¿ëµµº° ºÐ¼®(-2028³â)

Collagen Peptides Market Forecast to 2030 - Global Analysis by Source, Form, and Application

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 157 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Äݶó°Õ ÆéŸÀÌµå ½ÃÀåÀº 2023³â 9¾ï 9,895¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2030³â¿¡´Â 14¾ï 9,099¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 5.9%ÀÇ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

RousselotÀº ¼¼°è Äݶó°Õ ÆéŸÀÌµå ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ Áß Çϳª·Î Áß±¹, ÀϺ», Çѱ¹, È£ÁÖ, ´ºÁú·£µå, À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, ºÏ¹Ì, Áß³²¹Ì¿¡¼­ »ç¾÷À» ¿î¿µÇϰí ÀÖ½À´Ï´Ù. 2022³â 10¿ù, Äݶó°Õ ÆéŸÀ̵å¿Í Á©¶óƾ »ý»ê ´É·ÂÀ» È®´ëÇϱâ À§ÇØ ºê¶óÁú¿¡ º»»ç¸¦ µÐ Äݶó°Õ ¹× Á©¶óƾ Á¦Á¶¾÷üÀÎ Á©³Ø½º(Gelnex)¸¦ ÀμöÇß½À´Ï´Ù. ³²¹Ì¿¡ À§Ä¡ÇÑ Á©³Ø½ºÀÇ 5°³ »ý»ê½Ã¼³°ú ¹Ì±¹¿¡ À§Ä¡ÇÑ 1°³ »ý»ê½Ã¼³À» ÀμöÇØ Äݶó°Õ°ú Á©¶óƾÀÇ ¿¬°£ »ý»ê·®À» 46,000ÅæÀ¸·Î È®´ëÇß½À´Ï´Ù. ¶ÇÇÑ ¼ÒºñÀÚÀÇ »õ·Î¿î ¿ä±¸¿¡ ºÎÀÀÇÏ°í ´Ù¸¥ ½ÃÀå ±â¾÷°úÀÇ °æÀï ¿ìÀ§¸¦ È®º¸Çϱâ À§ÇØ Á¦Ç° Çõ½Å¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 1¿ù ·ç¼¿·ÔÀº ½ºÅ²ÄÉ¾î ¹× ¹Ì¿ë ½ÃÀåÀ» À§ÇÑ »õ·Î¿î ÇØ¾ç Äݶó°Õ ÆéŸÀÌµå ¼ººÐÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ Á¦Ç°Àº MSC ÀÎÁõÀ» ¹Þ¾ÒÀ¸¸ç, ÇØ¾ç »ýŰè¿Í »ý¹° ´Ù¾ç¼ºÀ» º¸È£ÇÏ´Â Áö¼Ó °¡´ÉÇÏ°í ¿ÏÀüÇÏ°Ô ÃßÀû °¡´ÉÇÑ ¾î¾÷ ¹æ½Ä¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç° Çõ½ÅÀº ¿¹Ãø ±â°£ µ¿¾È Áö¼ÓÀûÀ¸·Î ¼ºÀåÇÏ´Â Äݶó°Õ ÆéŸÀÌµå ½ÃÀå¿¡¼­ Á¦Á¶¾÷ü¿¡°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°ø±Þ¿ø¿¡ µû¶ó Äݶó°Õ ÆéŸÀÌµå ½ÃÀåÀº ¼Ò, µÅÁö, °¡±Ý·ù, ÇØ¾ç ¹× ±âŸ·Î ºÐ·ùµË´Ï´Ù. ¼Ò Äݶó°Õ ÆéŸÀÌµå ºÎ¹®Àº 2022³â ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÇØ¾ç Äݶó°Õ ÆéŸÀÌµå ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇØ¾ç Äݶó°ÕÀ» ¼·ÃëÇϸé ÇǺÎÀÇ Äݶó°Õ°ú ¿¤¶ó½ºÆ¾ ´Ü¹éÁú ¼¶À¯¸¦ º¹±¸Çϰí ÇǺΠ¹Ù±ùÂÊ(Ç¥ÇÇ)ÀÌ ´«¿¡ ¶ç°Ô µÎ²¨¿öÁö´Â °ÍÀ¸·Î ÀüÀÓ»ó½ÃÇè¿¡¼­ ³ªÅ¸³µ½À´Ï´Ù. ÇØ¾ç Äݶó°Õ ÆéŸÀ̵å´Â ¶óÀ̽Å, ÇÁ·Ñ¸°, ±Û¸®½Å, ÇÏÀÌµå ·Ï½Ã ÇÁ·Ñ¸°°ú °°Àº ¾Æ¹Ì³ë»êÀ¸·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. ÇÁ·Ñ¸°°ú ±Û¸®½ÅÀº »À °Ç°­À» ÁõÁø½Ãų »Ó¸¸ ¾Æ´Ï¶ó ÁÖ¿ä Ç×»êÈ­Á¦·Î ÀÛ¿ëÇÏ¿© ¼¼Æ÷¸¦ ¼Õ»ó½ÃŰ´Â Ȱ¼º»ê¼Ò·ÎºÎÅÍ º¸È£ÇÕ´Ï´Ù.

Äڷγª19ÀÇ ´ëÀ¯ÇàÀº ¼¼°è ¿©·¯ ±¹°¡ÀÇ °æÁ¦¿Í »ê¾÷¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç(APAC), Áß³²¹Ì(SAM), Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)ÀÇ ºÀ¼â, ¿©Çà Á¦ÇÑ, »ç¾÷ Áß´ÜÀº ½ÄÀ½·á, ÀǾàǰ ¹× °Ç°­º¸Á¶½Äǰ, ÆÛ½º³ÎÄÉ¾î »ê¾÷À» Æ÷ÇÔÇÑ ¿©·¯ »ê¾÷ÀÇ ¼ºÀåÀ» ÀúÇØÇß½À´Ï´Ù. Á¦Á¶ ºÎ¹®ÀÇ °¡µ¿ Áß´ÜÀº ¼¼°è °ø±Þ¸Á, Á¦Á¶ Ȱµ¿, ¹è¼Û ÀÏÁ¤, Çʼö Á¦Ç° ¹× ºñÇʼö Á¦Ç° ÆÇ¸Å¿¡ ÁöÀåÀ» ÃÊ·¡ÇßÀ¸¸ç, 2020³â¿¡´Â ´Ù¾çÇÑ ±â¾÷µéÀÌ Á¦Ç° ¹è¼Û Áö¿¬°ú Á¦Ç° ÆÇ¸Å ºÎÁøÀ» °Þ¾ú½À´Ï´Ù. ¶ÇÇÑ À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì °¢±¹ Á¤ºÎ°¡ ÇØ¿Ü¿©ÇàÀ» ±ÝÁöÇÔ¿¡ µû¶ó °¢ ±â¾÷Àº Á¦ÈÞ ¹× Çù·Â °èȹÀ» ÀϽÃÀûÀ¸·Î Áß´ÜÇÒ ¼ö¹Û¿¡ ¾ø¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ¸ðµç ¿äÀεéÀÌ 2020³â°ú 2021³â ÃÊ¿¡ ¿©·¯ »ê¾÷ÀÇ ¹ß¸ñÀ» Àâ°í Äݶó°Õ ÆéŸÀÌµå ½ÃÀåÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ½ÃÀåÀÇ ¼ºÀåÀ» ¾ïÁ¦Çß½À´Ï´Ù.

Áö¿ªº°·Î Äݶó°Õ ÆéŸÀÌµå ½ÃÀåÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç(APAC), Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA), Áß³²¹Ì·Î ±¸ºÐµÇ¸ç, 2022³â¿¡´Â ºÏ¹Ì°¡ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Äݶó°Õ ÆéŸÀ̵å´Â ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­ ¿µ¾ç È­Àåǰ ¼ººÐÀ¸·Î Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ±× °á°ú, Äݶó°ÕÀÌ °­È­µÈ ¾È¸é ¸¶½ºÅ© ¹× ±âŸ È­ÀåǰÀÌ ÀÌ Áö¿ªÀÇ ½ºÅ²ÄÉ¾î Æ®·»µå°¡ µÇ°í ÀÖ½À´Ï´Ù. ¾Æ¹Ì³ëÄݶó°Õ ÀÎµð¾Æ´Â ¸ÞÀÌÁö ¾Æ¹Ì³ëÄݶó°Õ ºê·£µå·Î Àεµ ¹Ì¿ë º¸Á¶Á¦ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù. ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀº ´Ù¾çÇÑ ¿ëµµÀÇ Äݶó°Õ ÆéŸÀ̵忡 ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ »ç¾÷À» È®ÀåÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 1¿ù ¹Ì±¹ ³²ºÎ ͏®Æ÷´Ï¾Æ¿¡ º»»ç¸¦ µÐ º¸ÃæÁ¦ ºê·£µåÀÎ Youtheory´Â Äݶó°Õ ±â¹Ý ºäƼ ¿Â´õ°í(Beauty On-The-Go) Á¦Ç°À» ÀϺ»À¸·Î È®ÀåÇÑ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. ¶ÇÇÑ, ½Ì°¡Æ÷¸£¿Í ÀϺ»¿¡¼­´Â °Ç°­º¸Á¶½ÄǰÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ À½½ÄÀ» Á¦°øÇÏ´Â 'ºäƼ ·¹½ºÅä¶û'ÀÌ ¿ÀÇÂÇßÀ¸¸ç, ±× Áß »ó´ç¼ö°¡ Äݶó°Õ ÆéŸÀÌµå ±â¹Ý ½Äǰ Á¦Á¦ÀÔ´Ï´Ù. ÀÌó·³ °Ç°­ º¸Á¶ ½ÄǰÀÇ ¿ø·á·Î Äݶó°Õ ÆéŸÀ̵åÀÇ ÀαⰡ ³ô¾ÆÁü¿¡ µû¶ó ÇâÈÄ ¸î ³âµ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Äݶó°Õ ÆéŸÀÌµå ½ÃÀå ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

GELITA AG, Rousselot BV, Titan Biotech Ltd, Tessenderlo Group NV, Ewald-Gelatine GmbH, BioCell Technology LLC, Lapi Gelatine SpA, Weishardt Holding SA, Nippi Collagen NA Inc, Nitta Gelatin India Ltd´Â Äݶó°Õ ÆéŸÀÌµå ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ÁÖ¿ä ±â¾÷ Áß ÇϳªÀÔ´Ï´Ù. ÀÌµé ±â¾÷Àº ¼¼°è ¼ÒºñÀÚ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ ½ÅÁ¦Ç° Ãâ½Ã¿Í Áö¸®Àû È®Àå¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù.

Àüü Äݶó°Õ ÆéŸÀÌµå ½ÃÀå ±Ô¸ð´Â 1Â÷ ¹× 2Â÷ Á¤º¸¸¦ ÅëÇØ »êÃâµÇ¾ú½À´Ï´Ù. ¿¬±¸ °úÁ¤À» ½ÃÀÛÇϸ鼭 ½ÃÀå°ú °ü·ÃµÈ ÁúÀû, ¾çÀû Á¤º¸¸¦ ¾ò±â À§ÇØ ³»ºÎ ¹× ¿ÜºÎ Ãâó¸¦ ÅëÇØ öÀúÇÑ 2Â÷ Á¶»ç¸¦ ½Ç½ÃÇß½À´Ï´Ù. ¶ÇÇÑ, µ¥ÀÌÅ͸¦ °ËÁõÇϰí ÁÖÁ¦¿¡ ´ëÇÑ º¸´Ù ½ÉÃþÀûÀÎ ºÐ¼®Àû ÅëÂû·ÂÀ» ¾ò±â À§ÇØ ¾÷°è °ü°èÀÚ¸¦ ´ë»óÀ¸·Î ¿©·¯ Â÷·ÊÀÇ 1Â÷ ÀÎÅͺ並 ÁøÇàÇß½À´Ï´Ù. ÀÌ °úÁ¤¿¡ Âü¿©ÇÑ ±â¾÷¿¡´Â Äݶó°Õ ÆéŸÀÌµå ½ÃÀå Àü¹® ºÎ»çÀå, ½ÃÀå °³Ã´ °ü¸®ÀÚ, ½ÃÀå Á¤º¸ °ü¸®ÀÚ, ±¹³» ¿µ¾÷ °ü¸®ÀÚ, Æò°¡ Àü¹®°¡, ¿¬±¸ ºÐ¼®°¡, ÁÖ¿ä ¿ÀÇǴϾ𠸮´õ¿Í °°Àº ¿ÜºÎ ÄÁ¼³ÅÏÆ®¿Í °°Àº ¾÷°è Àü¹®°¡°¡ Æ÷ÇԵ˴ϴÙ.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿äÁ¡

Á¦3Àå Á¶»ç ¹æ¹ý

  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¼öÁý
    • 1Â÷ ÀÎÅͺä
    • °¡¼³ Ã¥Á¤
    • °Å½Ã°æÁ¦ ¿äÀÎ ºÐ¼®
    • ±âÃÊ ¼öÄ¡ ÀÛ¼º
    • µ¥ÀÌÅÍ »ï°¢Ãø·®
    • ±¹°¡ ·¹º§ µ¥ÀÌÅÍ

Á¦4Àå Äݶó°Õ ÆéƼµå ½ÃÀå ±¸µµ

  • ½ÃÀå °³¿ä
  • PorterÀÇ Five Forces ºÐ¼®
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ¹ÙÀ̾îÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
    • ´ëüǰÀÇ À§Çù
  • Àü¹®°¡ÀÇ °ßÇØ
  • »ýÅÂ°è ºÐ¼®
    • ¿øÀç·á
    • »ý»ê °øÁ¤
    • ÃÖÁ¾ ÀÌ¿ë »ê¾÷

Á¦5Àå Äݶó°Õ ÆéƼµå ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ÇâÈÄ µ¿Çâ
  • ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇ⠺м®

Á¦6Àå ¼¼°èÀÇ Äݶó°Õ ÆéƼµå ½ÃÀå ºÐ¼®

  • Äݶó°Õ ÆéƼµå ½ÃÀå °³¿ä
  • °æÀï Æ÷Áö¼Å´× - ÁÖ¿ä ½ÃÀå ±â¾÷

Á¦7Àå Äݶó°Õ ÆéƼµå ½ÃÀå ºÐ¼® : °ø±Þ¿øº°

  • Äݶó°Õ ÆéƼµå ½ÃÀå : °ø±Þ¿øº°(2022³â ¹× 2030³â)
  • ¼Ò
  • µÅÁö
  • °¡±Ý·ù
  • ¼ö»ê
  • ±âŸ

Á¦8Àå Äݶó°Õ ÆéƼµå ½ÃÀå ºÐ¼® : Çüź°

  • Äݶó°Õ ÆéƼµå ½ÃÀå : Çüź°(2022³â, 2030³â)
  • °ÇÁ¶
  • ¾×ü

Á¦9Àå Äݶó°Õ ÆéƼµå ½ÃÀå ºÐ¼® : ¿ëµµº°

  • Äݶó°Õ ÆéƼµå ½ÃÀå : ¿ëµµº°(2022³â, 2030³â)
  • ½Äǰ ¹× À½·á
  • ÀǾàǰ ¹× ´ºÆ®¶ó½´Æ¼ÄÃ
  • ÆÛ½º³ÎÄɾî
  • ±âŸ

Á¦10Àå Äݶó°Õ ÆéƼµå ½ÃÀå : Áö¿ªº° ºÐ¼®

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • Áß³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ Áß³²¹Ì

Á¦11Àå COVID-19 ÆÒµ¥¹ÍÀÇ Äݶó°Õ ÆéƼµå ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ

  • COVID-19ÀÇ Äݶó°Õ ÆéƼµå ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • Áß³²¹Ì

Á¦12Àå ±â¾÷ °³¿ä

  • GELITA AG
  • Rousselot BV
  • Titan Biotech Ltd
  • Tessenderlo Group NV
  • Ewald-Gelatine GmbH
  • BioCell Technology LLC
  • Lapi Gelatine SpA
  • Weishardt Holding SA
  • Nippi Collagen NA Inc
  • Nitta Gelatin India Ltd

Á¦13Àå ºÎ·Ï

LSH 23.07.19

The collagen peptides market was valued at US$ 998.95 million in 2023 and is projected to reach US$ 1,490.99 million by 2030; it is expected to register a CAGR of 5.9% from 2023 to 2030.

Rousselot is among the major players in the global collagen peptides market, with operations across China, Japan, South Korea, Australia, New Zealand, Europe, the Middle East & Africa, North America, and South & Central America. The company is an independently operating subsidiary of Darling Ingredients Inc. In October 2022, the company acquired Gelnex, a Brazil-based collagen and gelatin producer, to expand its collagen peptide and gelatin production capacity. The company acquired five production facilities of Gelnex in South America and one in the US to expand its annual collagen and gelatin production to 46,000 metric tons. The company is also investing in product innovation to meet the emerging requirements of consumers and gain a competitive edge over other market players. For instance, in January 2021, Rousselot introduced a new marine collagen peptide ingredient for the skincare and beauty market. The product is MSC-certified, which meets the rising consumer demand for sustainable and fully traceable fishing practices that protect the ocean ecosystem and biodiversity. Such product innovations are expected to offer lucrative opportunities to manufacturers in the ever-growing collagen peptides market growth during the forecast period.

Based on source, the collagen peptides market is segmented into bovine, porcine, poultry, marine, and others. The bovine collagen peptides segment accounted for the largest share of the market in 2022, and the marine collagen peptides segment is expected to register the highest CAGR during the forecast period. Preclinical studies show that ingesting marine collagen repairs skin collagen and elastin protein fibers and causes a significant thickening of the outer skin surface (epidermis). Marine collagen peptides consist of lysine, proline, glycine, and hydroxyproline, among other amino acids. In addition to promoting bone health, proline and glycine act as major antioxidants and provide protection against free radicals that cause cell damage.

The COVID-19 pandemic affected economies and industries in several countries across the globe. Lockdowns, travel restrictions, and business shutdowns in North America, Europe, Asia Pacific (APAC), South & Central America (SAM), and the Middle East & Africa (MEA) hampered the growth of several industries, including the food & beverages, pharmaceutical & nutraceutical, and personal care industries. The shutdown of manufacturing units disturbed global supply chains, manufacturing activities, delivery schedules, and essential and nonessential product sales. Various companies witnessed delays in product deliveries and a slump in sales of their products in 2020. Moreover, the bans imposed by governments of various countries in Europe, Asia Pacific, and North America on international travel compelled companies to discontinue their collaboration and partnership plans temporarily. All these factors hampered multiple industries in 2020 and early 2021, thereby restraining the growth of various markets, including the collagen peptides market.

Geographically, the collagen peptides market is segmented into North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. In 2022, North America held the largest share of the collagen peptides market, and Asia Pacific is estimated to register the highest CAGR over the forecast period. Collagen peptides are gaining popularity as a nutricosmetic component in Asia Pacific. As a result, collagen-enriched face masks and other cosmetic products are becoming a skincare trend in the region. Amino Collagen India is a major player in the Indian beauty supplement market, operating under the Meiji Amino Collagen brand. The key players in the market are taking initiatives to expand their business and cater to the growing demand for collagen peptides in various applications. For instance, in January 2023, Youtheory-a Southern California-based supplement brand-announced the expansion of its collagen-based Beauty On-The-Go Product in Japan. In addition, Singapore and Japan have opened "beauty restaurants," which offer a variety of delicacies containing dietary supplements, many of which are collagen peptide-based food preparations. Thus, the growing popularity of collagen peptides as an ingredient in nutricosmetic products is expected to drive the collagen peptides market growth in Asia Pacific in the coming years.

GELITA AG, Rousselot BV, Titan Biotech Ltd, Tessenderlo Group NV, Ewald-Gelatine GmbH, BioCell Technology LLC, Lapi Gelatine SpA, Weishardt Holding SA, Nippi Collagen NA Inc, and Nitta Gelatin India Ltd are among the key players operating in the collagen peptides market. These companies are focused on new product launches and geographic expansions to meet the growing consumer demand worldwide.

The overall collagen peptides market size has been derived using primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain more analytical insights into the topic. The participants of this process include industry experts such as VPs; business development managers; market intelligence managers; national sales managers; and external consultants, including valuation experts, research analysts, and key opinion leaders, specializing in the collagen peptides market.

Reasons to Buy:

  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global collagen peptides market, thereby allowing players to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth the market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation, and industry verticals.

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation

2. Key Takeaways

3. Research Methodology

  • 3.1 Scope of the Study
  • 3.2 Research Methodology
    • 3.2.1 Data Collection:
    • 3.2.2 Primary Interviews:
    • 3.2.3 Hypothesis Formulation:
    • 3.2.4 Macro-economic Factor Analysis:
    • 3.2.5 Developing Base Number:
    • 3.2.6 Data Triangulation:
    • 3.2.7 Country Level Data:

4. Collagen Peptides Market Landscape

  • 4.1 Market Overview
  • 4.2 Porter's Five Forces Analysis
    • 4.2.1 Bargaining Power of Suppliers
    • 4.2.2 Bargaining Power of Buyers
    • 4.2.3 Threat of New Entrants
    • 4.2.4 Competitive Rivalry
    • 4.2.5 Threat of Substitutes
  • 4.3 Expert Opinion
  • 4.4 Ecosystem Analysis
    • 4.4.1 Raw Materials
    • 4.4.2 Production Process
    • 4.4.3 End-Use Industries

5. Collagen Peptides Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Wide Application Scope
    • 5.1.2 Strategic Development Initiatives by Key Market Players
  • 5.2 Market Restraints
    • 5.2.1 Safety Concerns and Stringent Regulations Related to Consumption of Collagen Peptides
  • 5.3 Market Opportunities
    • 5.3.1 Surging Demand for Marine-Sourced Collagen Peptides
  • 5.4 Future Trends
    • 5.4.1 Escalating Trend of Using Collagen Peptides in Personal Care and Nutricosmetics
  • 5.5 Impact Analysis of Drivers and Restraints

6. Collagen Peptides - Global Market Analysis

  • 6.1 Collagen Peptides Market Overview
  • 6.2 Collagen Peptides Market -Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Competitive Positioning - Key Market Players

7. Collagen Peptides Market Analysis - By Source

  • 7.1 Overview
  • 7.2 Collagen Peptides Market, By Source (2022 and 2030)
  • 7.3 Bovine
    • 7.3.1 Overview
    • 7.3.2 Bovine: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Porcine
    • 7.4.1 Overview
    • 7.4.2 Porcine: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Poultry:
    • 7.5.1 Overview
    • 7.5.2 Poultry: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Marine:
    • 7.6.1 Overview
    • 7.6.2 Marine: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Collagen Peptides Market- Revenue and Forecast to 2030 (US$ Million)

8. Collagen Peptides Market Analysis - By Form

  • 8.1 Overview
  • 8.2 Collagen Peptides Market, By Form (2022 and 2030)
  • 8.3 Dry
    • 8.3.1 Overview
    • 8.3.2 Dry: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Liquid
    • 8.4.1 Overview
    • 8.4.2 Liquid: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)

9. Collagen Peptides Market Analysis - By Application

  • 9.1 Overview
  • 9.2 Collagen Peptides Market, By Application (2022 and 2030)
  • 9.3 Food and Beverages
    • 9.3.1 Overview
    • 9.3.2 Food and Beverages: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Pharmaceuticals and Nutraceuticals
    • 9.4.1 Overview
    • 9.4.2 Pharmaceuticals and Nutraceuticals: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Personal Care
    • 9.5.1 Overview
    • 9.5.2 Personal Care: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)

10. Collagen Peptides Market - Geographic Analysis

  • 10.1 Overview
  • 10.2 North America: Collagen Peptides Market
    • 10.2.1 North America: Collagen Peptides Market -Revenue and Forecast to 2030 (US$ Million)
    • 10.2.2 North America: Collagen Peptides Market, By Source
    • 10.2.3 North America: Collagen Peptides Market, By Form
    • 10.2.4 North America: Collagen Peptides Market, by Application
    • 10.2.5 North America: Collagen Peptides Market, by Key Country
      • 10.2.5.1 US: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.1.1 US: Collagen Peptides Market, By Source
        • 10.2.5.1.2 US: Collagen Peptides Market, By Form
        • 10.2.5.1.3 US: Collagen Peptides Market, by Application
      • 10.2.5.2 Canada: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.2.1 Canada: Collagen Peptides Market, By Source
        • 10.2.5.2.2 Canada: Collagen Peptides Market, By Form
        • 10.2.5.2.3 Canada: Collagen Peptides Market, by Application
      • 10.2.5.3 Mexico: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.5.3.1 Mexico: Collagen Peptides Market, By Source
        • 10.2.5.3.2 Mexico: Collagen Peptides Market, By Form
        • 10.2.5.3.3 Mexico: Collagen Peptides Market, by Application
  • 10.3 Europe: Collagen Peptides Market
    • 10.3.1 Europe: Collagen Peptides Market -Revenue and Forecast to 2030 (US$ Million)
    • 10.3.2 Europe: Collagen Peptides Market, By Source
    • 10.3.3 Europe: Collagen Peptides Market, By Source
    • 10.3.4 Europe: Collagen Peptides Market, by Application
    • 10.3.5 Europe: Collagen Peptides Market, by Key Country
      • 10.3.5.1 Germany: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.1.1 Germany: Collagen Peptides Market, By Source
        • 10.3.5.1.2 Germany: Collagen Peptides Market, By Form
        • 10.3.5.1.3 Germany: Collagen Peptides Market, by Application
      • 10.3.5.2 UK: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.2.1 UK: Collagen Peptides Market, By Source
        • 10.3.5.2.2 UK: Collagen Peptides Market, By Form
        • 10.3.5.2.3 UK: Collagen Peptides Market, by Application
      • 10.3.5.3 France: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.3.1 France: Collagen Peptides Market, By Source
        • 10.3.5.3.2 France: Collagen Peptides Market, By Form
        • 10.3.5.3.3 France: Collagen Peptides Market, by Application
      • 10.3.5.4 Italy: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.4.1 Italy: Collagen Peptides Market, By Source
        • 10.3.5.4.2 Italy: Collagen Peptides Market, By Form
        • 10.3.5.4.3 Italy: Collagen Peptides Market, by Application
      • 10.3.5.5 Russia: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.5.1 Russia: Collagen Peptides Market, By Source
        • 10.3.5.5.2 Russia: Collagen Peptides Market, By Form
        • 10.3.5.5.3 Russia: Collagen Peptides Market, by Application
      • 10.3.5.6 Rest of Europe: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.5.6.1 Rest of Europe: Collagen Peptides Market, By Source
        • 10.3.5.6.2 Rest of Europe: Collagen Peptides Market, By Form
        • 10.3.5.6.3 Rest of Europe: Collagen Peptides Market, by Application
  • 10.4 Asia Pacific: Collagen Peptides Market
    • 10.4.1 Asia Pacific: Collagen Peptides Market -Revenue and Forecast to 2030 (US$ Million)
    • 10.4.2 Asia Pacific: Collagen Peptides Market, By Source
    • 10.4.3 Asia Pacific: Collagen Peptides Market, By Form
    • 10.4.4 Asia Pacific: Collagen Peptides Market, by Application
    • 10.4.5 Asia Pacific: Collagen Peptides Market, by Key Country
      • 10.4.5.1 China: Collagen Peptides Market -Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.1.1 China: Collagen Peptides Market, By Source
        • 10.4.5.1.2 China: Collagen Peptides Market, By Form
        • 10.4.5.1.3 China: Collagen Peptides Market, by Application
      • 10.4.5.2 Japan: Collagen Peptides Market -Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.2.1 Japan: Collagen Peptides Market, By Source
        • 10.4.5.2.2 Japan: Collagen Peptides Market, By Form
        • 10.4.5.2.3 Japan: Collagen Peptides Market, by Application
      • 10.4.5.3 India: Collagen Peptides Market -Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.3.1 India: Collagen Peptides Market, by Source
        • 10.4.5.3.2 India: Collagen Peptides Market, by Form
        • 10.4.5.3.3 India: Collagen Peptides Market, by Application
      • 10.4.5.4 Australia: Collagen Peptides Market -Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.4.1 Australia: Collagen Peptides Market, By Source
        • 10.4.5.4.2 Australia: Collagen Peptides Market, By Form
        • 10.4.5.4.3 Australia: Collagen Peptides Market, by Application
      • 10.4.5.5 South Korea: Collagen Peptides Market -Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.5.1 South Korea: Collagen Peptides Market, By Source
        • 10.4.5.5.2 South Korea: Collagen Peptides Market, By Form
        • 10.4.5.5.3 South Korea: Collagen Peptides Market, by Application
      • 10.4.5.6 Rest of Asia Pacific: Collagen Peptides Market -Revenue and Forecast to 2030 (US$ Million)
        • 10.4.5.6.1 Rest of Asia Pacific: Collagen Peptides Market, By Source
        • 10.4.5.6.2 Rest of Asia Pacific: Collagen Peptides Market, By Form
        • 10.4.5.6.3 Rest of Asia Pacific: Collagen Peptides Market, by Application
  • 10.5 Middle East & Africa: Collagen Peptides Market
    • 10.5.1 Middle East & Africa: Collagen Peptides Market -Revenue and Forecast to 2030 (US$ Million)
    • 10.5.2 Middle East & Africa: Collagen Peptides Market, By Source
    • 10.5.3 Middle East & Africa: Collagen Peptides Market, By Form
    • 10.5.4 Middle East & Africa: Collagen Peptides Market, by Application
    • 10.5.5 Middle East & Africa: Collagen Peptides Market, by Key Country
      • 10.5.5.1 Saudi Arabia: Collagen Peptides Market -Revenue and Forecast to 2030 (US$ Million)
        • 10.5.5.1.1 Saudi Arabia: Collagen Peptides Market, By Source
        • 10.5.5.1.2 Saudi Arabia: Collagen Peptides Market, By Form
        • 10.5.5.1.3 Saudi Arabia: Collagen Peptides Market, by Application
      • 10.5.5.2 UAE: Collagen Peptides Market -Revenue and Forecast to 2030 (US$ Million)
        • 10.5.5.2.1 UAE: Collagen Peptides Market, By Source
        • 10.5.5.2.2 UAE: Collagen Peptides Market, By Form
        • 10.5.5.2.3 UAE: Collagen Peptides Market, by Application
      • 10.5.5.3 South Africa: Collagen Peptides Market -Revenue and Forecast to 2030 (US$ Million)
        • 10.5.5.3.1 South Africa: Collagen Peptides Market, By Source
        • 10.5.5.3.2 South Africa: Collagen Peptides Market, By Form
        • 10.5.5.3.3 South Africa: Collagen Peptides Market, By Application
      • 10.5.5.4 Rest of Middle East & Africa: Collagen Peptides Market -Revenue and Forecast to 2030 (US$ Million)
        • 10.5.5.4.1 Rest of Middle East & Africa: Collagen Peptides Market, by Source
        • 10.5.5.4.2 Rest of Middle East & Africa: Collagen Peptides Market, by Form
        • 10.5.5.4.3 Rest of Middle East & Africa: Collagen Peptides Market, by Application
  • 10.6 South & Central America: Collagen Peptides Market
    • 10.6.1 South & Central America: Collagen Peptides Market -Revenue and Forecast to 2030 (US$ Million)
    • 10.6.2 South & Central America: Collagen Peptides Market, By Source
    • 10.6.3 South & Central America: Collagen Peptides Market, By Form
    • 10.6.4 South & Central America: Collagen Peptides Market, by Application
    • 10.6.5 South & Central America: Collagen Peptides Market, by Key Country
      • 10.6.5.1 Brazil: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.6.5.1.1 Brazil: Collagen Peptides Market, By Source
        • 10.6.5.1.2 Brazil: Collagen Peptides Market, By Form
        • 10.6.5.1.3 Brazil: Collagen Peptides Market, by Application
      • 10.6.5.2 Argentina: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.6.5.2.1 Argentina: Collagen Peptides Market, By Source
        • 10.6.5.2.2 Argentina: Collagen Peptides Market, By Form
        • 10.6.5.2.3 Argentina: Collagen Peptides Market, by Application
      • 10.6.5.3 Rest of South & Central America: Collagen Peptides Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.6.5.3.1 Rest of South & Central America: Collagen Peptides Market, By Source
        • 10.6.5.3.2 Rest of South & Central America: Collagen Peptides Market, By Form
        • 10.6.5.3.3 Rest of South & Central America: Collagen Peptides Market, by Application

11. Impact Of COVID-19 Pandemic on Collagen Peptides Market

  • 11.1 Impact of COVID-19 on Collagen Peptides Market
  • 11.2 North America: Impact Assessment of COVID-19 Pandemic
  • 11.3 Europe Impact Assessment of COVID-19 Pandemic
  • 11.4 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
  • 11.5 South & Central America: Impact Assessment of COVID-19 Pandemic

12. Company Profiles

  • 12.1 GELITA AG
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Rousselot BV
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Titan Biotech Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Tessenderlo Group NV
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Ewald-Gelatine GmbH
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 BioCell Technology LLC
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Lapi Gelatine SpA
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Weishardt Holding SA
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Nippi Collagen NA Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Nitta Gelatin India Ltd
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Word Index
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦